One swallow does not a summer make but many swallows do: accumulating clinical evidence for nearly-eliminated peri-procedural and 30-day complications with mesh-covered stents transforms the carotid revascularisation field
Piotr Musiałek, L Nelson Hopkins, Adnan H Siddiqui, Piotr Musiałek, L Nelson Hopkins, Adnan H Siddiqui
Abstract
Atherosclerotic carotid artery stenosis (CS) continues to be a common cause of acute ischaemic stroke. Optimised medical therapy (OMT), the first-line treatment modality in CS, may reduce or delay - but it does not abolish - CS-related strokes. As per current AHA/ASA and ESC/ESVS/ESO guidelines, carotid artery stenting (CAS) is a less-invasive alternative to carotid endarterectomy (CEA) for CS revascularisation in primary and secondary stroke prevention. Ten-year follow-up from the CREST trial in patients with symptomatic and asymptomatic CS confirmed equipoise of CAS and CEA in the primary endpoint. Nevertheless CAS - using a widely open-cell, first-generation stent and first-generation (distal/filter) neuroprotection - has been criticised for its relative excess of (mostly minor) strokes by 30 days, a significant proportion of which were post-procedural. Atherosclerotic plaque protrusion through conventional carotid stent struts, confirmed on intravascular imaging, has been implicated as a leading mechanism of the relative excess of strokes with CAS vs. CEA, including delayed strokes with CAS. Different designs of mesh-covered carotid stents have been developed to prevent plaque prolapse. Several multi-centre/multi-specialty clinical studies with CGurad MicroNet-Covered Embolic Prevention Stent System (EPS) and RoadSaver/Casper were recently published and included routine DW-MRI cerebral imaging peri-procedurally and at 30 days (CGuard EPS). Data from more than 550 patients in mesh-covered carotid stent clinical studies to-date show an overall 30-day complication rate of ~1% with near-elimination of post-procedural events. While more (and long-term) evidence is still anticipated, these results - taken together with optimised intra-procedural neuroprotection in CAS (increased use of proximal systems including trans-carotid dynamic flow reversal) and the positive 12-month mesh-covered stent data reports in 2017 - are transforming the carotid revascularisation field today. Establishing effective algorithms to identify the asymptomatic subjects at stroke risk despite OMT, and large-scale studies with mesh-covered stents including long-term clinical and duplex ultrasound outcomes, are the next major goals.
Keywords: carotid artery stenting; endarterectomy; mesh; neuroprotection; stroke.
References
- Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics – 2016 Update: a Report from the American Heart Association. Circulation. 2016;133:e38–60.
- Rangel-Castilla L, Rajah GB, Shakir HJ, et al. Endovascular prevention and treatment of stroke related to extracranial carotid artery disease. J Cardiovasc Surg. 2017;58:35–48.
- Mpotsaris A, Kabbasch C, Borggrefe J, et al. Stenting of the cervical internal carotid artery in acute stroke management: the Karolinska experience. Interv Neuroradiol. 2017;23:159–65.
- Kappelhof M, Marquering HA, Berkhemer OA, Majoie CB. Intra-arterial treatment of patients with acute ischemic stroke and internal carotid artery occlusion: a literature review. J Neurointerv Surg. 2015;7:8–15.
- Musialek P, Mazurek A, Trystula M, et al. Novel PARADIGM in carotid revascularisation: prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system. EuroIntervention. 2016;12:e658–70.
- Bosiers M, Deloose K, Torsello G, et al. The CLEAR-ROAD study: evaluation of a new dual layer micromesh stent system for the carotid artery. EuroIntervention. 2016;12:e671–6.
- Nerla R, Castriota F, Micari A, et al. Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres: clinical results of a multidisciplinary approach. EuroIntervention. 2016;12:e677–83.
- Kotsugi M, Takayama K, Myouchin K, et al. Carotid artery stenting: investigation of plaque protrusion incidence and prognosis. JACC Cardiovasc Interv. 2017;10:824–31.
- Conrad MF, Boulom V, Mukhopadhyay S, et al. Progression of asymptomatic carotid stenosis despite optimal medical therapy. J Vasc Surg. 2013;58:128–35.
- Musialek P, Hopf-Jensen S. Carotid artery revascularization for stroke prevention: a new era. J Endovasc Ther. 2017;24:138–48.
- Sabeti S, Schlager O, Exner M, et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke. 2007;38:2887–94.
- Paraskevas KI, Nicolaides AN, Veith FJ. Carotid endarterectomy may be required in addition to best medical treatment for some patient subgroups with asymptomatic carotid stenosis. Vascular. 2015;23:62–4.
- Paraskevas KI, Mikhailidis DP, Veith FJ, Spence JD. Definition of best medical treatment in asymptomatic and symptomatic carotid artery stenosis. Angiology. 2016;67:411–9.
- Fisher M, Paganini-Hill A, Martin A, et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke. 2005;36:253–7.
- Virmani R, Ladich ER, Burke AP, Kolodgie FD. Histopathology of carotid atherosclerotic disease. Neurosurgery. 2006;59(Suppl 3):S219–27.
- Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–236.
- Widimsky P, Kolh P, Agewall, et al. Eur Heart J. 2017. 2017 European Society of Cardiology (ESC) Guidelines on the diagnosis and Treatment of Peripheral Arterial Disease – in collaboration with the European Society of Vascular Surgery (ESVS) and European Stroke Organization (ESO) (in press)
- Eller JL, Snyder KV, Siddiqui AH, et al. Endovascular treatment of carotid stenosis. Neurosurg Clin N Am. 2014;25:565–82.
- Papanagiotou P, Roth C, Walter S, et al. Carotid artery stenting in acute stroke. J Am Coll Cardiol. 2011;58:2363–9.
- Wach MM, Dumont TM, Mokin M, et al. Early carotid angioplasty and stenting may offer non-inferior treatment for symptomatic cases of carotid artery stenosis. J Neurointerv Surg. 2014;6:276–80.
- Brott TG, Howard G, Roubin GS, et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med. 2016;374:1021–31.
- Mousa A, Broce M. Carotid endarterectomy before and after CREST. J Endovasc Ther. 2016;23:536–7.
- Aksoy O, Kapadia SR, Bajzer C, et al. Carotid stenting vs surgery: parsing the risk of stroke and MI. Cleve Clin J Med. 2010;77:892–902.
- Brott TG, Hobson RW, 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23.
- Sardar P, Chatterjee S, Aronow HD, et al. Carotid artery stenting versus endarterectomy for stroke prevention: a meta-analysis of clinical trials. J Am Coll Cardiol. 2017;69:2266–75.
- Hill MD, Brooks W, Mackey A, et al. Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) Circulation. 2012;126:3054–61.
- Blackshear JL, Cutlip DE, Roubin GS, et al. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation. 2011;123:2571–8.
- Stilp E, Baird C, Gray WA, et al. An evidence-based review of the impact of periprocedural myocardial infarction in carotid revascularization. Catheter Cardiovasc Interv. 2013;82:709–14.
- Paraskevas KI, Kalmykov EL, Naylor AR. Stroke/death rates following carotid artery stenting and carotid endarterectomy in contemporary administrative dataset registries: a systematic review. Eur J Vasc Endovasc Surg. 2016;51:3–12.
- Chaturvedi S, Madhavan R, Santhakumar S, et al. Higher risk factor burden and worse outcomes in urban carotid endarterectomy patients. Stroke. 2008;39:2966–8.
- Nikas D, Reith W, Schmidt A, et al. Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv. 2012;80:1060–8.
- Ansel GM, Hopkins LN, Jaff MR, et al. Safety and effectiveness of the INVATEC proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv. 2010;76:1–8.
- Clair DG, Hopkins LN, Mehta M, et al. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv. 2011;77:420–9.
- Mokin M, Dumont TM, Chi JM, et al. Proximal versus distal protection during carotid artery stenting: analysis of the two treatment approaches and associated clinical outcomes. World Neurosurg. 2014;81:543–8.
- Pinter L, Ribo M, Loh C, et al. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study. J Vasc Surg. 2011;54:1317–23.
- Kwolek CJ, Jaff MR, Leal JI, et al. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. J Vasc Surg. 2015;62:1227–34.
- Pieniazek P, Musialek P, Kablak-Ziembicka A, et al. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS) J Endovasc Ther. 2008;15:249–62.
- Leal I, Orgaz A, Flores Á, et al. A diffusion-weighted magnetic resonance imaging-based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection. J Vasc Surg. 2012;56:1585–90.
- Montorsi P, Caputi L, Galli S, et al. Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection. J Am Coll Cardiol. 2011;58:1656–63.
- Stabile E, Sannino A, Schiattarella GG, et al. Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. JACC Cardiovasc Interv. 2014;7:1177–83.
- Pieniążek P, Tekieli L, Musiałek P, et al. Carotid artery stenting according to the tailored-CAS algorithm is associated with a low complication rate at 30 days: data from the TARGET-CAS study. Kardiol Pol. 2012;70:378–86.
- Paraskevas KI, Veith FJ, Parodi JC. Transcervical carotid artery senting (CAS) with flow reversal: a promising technique for the reduction of strokes associated with CAS. J Endovasc Ther. 2016;23:255–7.
- Grunwald IQ, Reith W, Kühn AL, et al. Proximal protection with the Gore PAES can reduce DWI lesion size in high-grade stenosis during carotid stenting. EuroIntervention. 2014;10:271–6.
- Cremonesi A, Gieowarsingh S, Spagnolo B, et al. Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: the tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry) EuroIntervention. 2009;5:589–98.
- Pieniazek P, Musialek P, Dzierwa K, et al. Flow reversal for proximal neuroprotection during endovascular management of critical symptomatic carotid artery stenosis coexisting with ipsilateral external carotid artery occlusion. J Endovasc Ther. 2009;16:744–51.
- Bosiers M, de Donato G, Deloose K, et al. Does free cell area influence the outcome in carotid artery stenting? Eur J Vasc Endovasc Surg. 2007;33:135–41.
- Tietke M, Jansen O. Cerebral protection vs. no cerebral protection: timing of stroke with CAS. J Cardiovasc Surg. 2009;50:751–60.
- Doig D, Turner EL, Dobson J, et al. Predictors of stroke, myocardial infarction or death within 30 days of carotid artery stenting: results from the International Carotid Stenting Study. Eur J Vasc Endovasc Surg. 2016;51:327–34.
- Tatli E, Tokatli A, Vatan MB, et al. Comparison of closed-cell and hybrid-cell stent designs in carotid artery stenting: clinical and procedural outcomes. Adv Interv Cardiol. 2017;13:135–41.
- Stabile E, Giugliano G, Cremonesi A, et al. Impact on outcome of different types of carotid stent: results from the European Registry of Carotid Artery Stenting. EuroIntervention. 2016;12:e265–70.
- Al-Mubarak N, Roubin GS, Vitek JJ, et al. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 2001;104:1999–2002.
- Macdonald S, Evans DH, Griffiths PD, et al. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis. 2010;29:282–9.
- Tulip HH, Rosero EB, Higuera AJ, et al. Cerebral embolization in asymptomatic versus symptomatic patients after carotid stenting. J Vasc Surg. 2012;56:1579–84.
- Fairman R, Gray WA, Scicli AP, et al. The CAPTURE registry: analysis of strokes resulting from carotid artery stenting in the post approval setting: timing, location, severity, and type. Ann Surg. 2007;246:551–6.
- Schofer J, Arendt M, Tübler T, et al. Late cerebral embolization after emboli-protected carotid artery stenting assessed by sequential diffusion-weighted magnetic resonance imaging. JACC Cardiovasc Interv. 2008;1:571–7.
- Reimers B, Nikas D, Stabile E, et al. Preliminary experience with optical coherence tomography imaging to evaluate carotid artery stents: safety, feasibility, and techniques. EuroIntervention. 2011;7:98–105.
- De Donato G, Setacci F, Sirignano P, et al. Optical coherence tomography after carotid stenting: rate of stent malapposition, plaque prolapse and fibrous cap rupture according to stent design. Eur J Vasc Endovasc Surg. 2013;45:579–87.
- Shinozaki N, Ogata N, Ikari Y. Plaque protrusion detected by intravascular ultrasound during carotid artery stenting. J Stroke Cerebrovasc Dis. 2014;23:2622–5.
- Liu R, Jiang Y, Xiong Y, et al. An optical coherence tomography assessment of stent strut apposition based on the presence of lipid-rich plaque in the carotid artery. J Endovasc Ther. 2015;22:942–9.
- Schofer J, Musiałek P, Bijuklic K, et al. A prospective, multicenter study of a novel mesh-covered carotid stent: the CGuard CARENET Trial (Carotid Embolic Protection Using MicroNET) JACC Cardiovasc Interv. 2015;8:1229–34.
- Wissgott C, Schmidt W, Brandt-Wunderlich C, et al. Clinical results and mechanical properties of the CGuard double-layered embolic protection stent. J Endovasc Ther. 2017;24:130–7.
- Machnik R, Paluszek P, Tekieli L, et al. Mesh-covered (Roadsaver) stent as a new treatment modality for symptomatic or high-risk carotid stenosis. Adv Interv Cardiol. 2017;13:130–4.
- Speziale F, Capoccia L, Sirignano P, et al. 30-day results from prospective multi-specialty evaluation of carotid artery stenting using the CGuard micronet-covered embolic prevention stent system in real world multicenter clinical practice: the IRON-GUARD study. EuroIntervention. 2017 May 9; [Epub ahead of print]
- Ziaja K, Kuczmik W. Carotid artery stenting: In whom? When? How? And by whom? – The vascular surgeon point of view [Polish] Medycyna Praktyczna – Kardiologia () 2009;3:5–12.
- Plessers M, Van Herzeele I, Hemelsoet D, et al. Transcervical carotid stenting with dynamic flow reversal demonstrates embolization rates comparable to carotid endarterectomy. J Endovasc Ther. 2016;23:249–54.
- Musialek P, Trystula M. Impact Of TCAR And Micro-Mesh Stent Usage With The C-Guard Stent (Inspire MD) On CAS: Do They Decrease DW MRI Cerebral Embolic Lesions and Which Helps Most? New York, NY, USA: Invited Lecture at VEITH Congress (Vascular Endovascular Issues Techniques Horizons; 2016. Nov 18, presented on. available at ; accessed 12 June 2017.
- Park KY, Kim DI, Kim BM, et al. Incidence of embolism associated with carotid artery stenting: open-cell versus closed-cell stents. J Neurosurg. 2013;119:642–7.
- Paraskevas KI, Mikhailidis DP, Veith FJ. Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomes. J Vasc Surg. 2010;52:1367–75.
- Mas JL, Trinquart L, Leys D, et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7:885–92.
- Musialek P. Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date Invited. Lecture at Transcatheter Cardiovascular Therapeutics (TCT 2015), Carotid and Stroke Intervention: State of the Art Session. 2015. Oct 14, Available at (accessed 12 June 2017)
- Hopf-Jensen S, Marques L, Preiß M, Müller-Hülsbeck S. Initial clinical experience with the micromesh Roadsaver carotid artery stent for the treatment of patients with symptomatic carotid artery disease. J Endovasc Ther. 2015;22:220–5.
- Wissgott C, Schmidt W, Brandt-Wunderlich C, et al. Preliminary clinical results and mechanical behavior of a new double-layer carotid stent. J Endovasc Ther. 2015;22:634–9.
- Schönholz C, Yamada R, Montgomery W, et al. First-in-man implantation of a new hybrid carotid stent to prevent periprocedural neurological events during carotid artery stenting. J Endovasc Ther. 2014;21:601–4.
- Yamada R, Guimaraes M, Adams J, Schönholz C. New technologies for CAS that might overcome the burden of microembolization. J Cardiovasc Surg. 2015;56:859–65.
- Bijuklic K, Wandler A, Hazizi F, Schofer J. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. J Am Coll Cardiol. 2012;59:1383–9.
- Siddiqui AH, Hopkins LN. Asymptomatic carotid stenosis – the not-so-silent disease: changing perspectives from thromboembolism to cognition. J Am Coll Cardiol. 2013;61:2510–3.
- Grunwald IQ, Supprian T, Politi M, et al. Cognitive changes after carotid artery stenting. Neuroradiology. 2006;48:319–23.
- Cheng Y, Wang YJ, Yan JC, et al. Effects of carotid artery stenting on cognitive function in patients with mild cognitive impairment and carotid stenosis. Exp Ther Med. 2013;5:1019–24.
- Grunwald IQ, Papanagiotou P, Reith W, et al. Influence of carotid artery stenting on cognitive function. Neuroradiology. 2010;52:61–6.
- Antonopoulos CN, Kakisis JD, Sfyroeras GS, et al. The impact of carotid artery stenting on cognitive function in patients with extracranial carotid artery stenosis. Ann Vasc Surg. 2015;29:457–69.
- Watanabe J, Ogata T, Higashi T, Inoue T. Cognitive change 1 year after CEA or CAS compared with medication. J Stroke Cerebrovasc Dis. 2017;26:1297–305.
- Hitchner E, Baughman BD, Soman S, et al. Microembolization is associated with transient cognitive decline in patients undergoing carotid interventions. J Vasc Surg. 2016;64:1719–25.
- Zhou W, Baughman BD, Soman S, et al. Volume of subclinical embolic infarct correlates to long-term cognitive changes after carotid revascularization. J Vasc Surg. 2017;65:686–94.
- Ruffino MA, Rabbia C. New ischemic brain lesions on DW-MRI after CAS with double-layer stents. Data presented at Leipzig Interventional Course (LINC); 2016. Available at: (accessed 12 June 2017)
- Musialek P, Bijuklic K, Kolvenbach R, et al. Twelve-month Clinical and Duplex Ultrasound Outcome From the CGuard™ CARENET Prospective Multicenter Trial: CARotid Embolic Prevention using MicroNET-Covered Stent System in Patients with Symptomatic and Asymptomatic Carotid Artery Stenosis (manuscript at review; data presented at LINC 2017 in: Musialek P. CGuard™ MicroNET-covered embolic prevention system routine use in carotid revascularization for stroke prevention: Accumulating clinical evidence. Available at ; (accessed 12 June 2017)
- Musialek P, Mazurek A, Trystula M, et al. Durability of stroke prevention using a dual-layer stent system in carotid revascularization in symptomatic and increased-stroke-risk asymptomatic patients: 12-month evidence from the PARADIGM study – ESC 2017 Best Poster. (Abstract) Eur Hear J (Suppl) 2017 in press.
- Roffi M, Musialek P. EuroPCR 2017 Highlights: Peripheral Interventions. PCR TV. Available at (accessed 12 June 2017)
- Fröbert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587–97.
- Musialek P. TASTE-less endpoint of 30-day mortality (and some other issues with TASTE) in evaluating the effectiveness of thrombus aspiration in STEMI: Not the “evidence” to change the current practice of routine consideration of manual thrombus extraction. Kardiol Pol. 2014;72:479–87.
- Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.
- Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014;35:2541–619.
- Serruys PW, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med. 2010;363:136–46.
- Paraskevas KI, Veith FJ. Techniques and innovations to improve carotid artery stenting outcomes. Int J Cardiol. 2016;222:986–7.
- Musialek P, Pieniazek P. Restenosis after carotid artery stenting versus endarterectomy: the jury is still out! J Endovasc Ther. 2010;17:271–2.
- Musialek P, Tracz W, Tekieli L, et al. Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis. J Clin Neurol. 2013;9:165–75.
- Heck DV, Roubin GS, Rosenfield KG, et al. Asymptomatic carotid stenosis: medicine alone or combined with carotid revascularization. Neurology. 2017;88:2061–5.
- Paraskevas KI, Veith FJ. Transcervical access, reversal of flow and mesh-covered stents: new options in the armamentarium of carotid artery stenting. World J Cardiol. 2017;9:416–21.
- Naylor AR. SPACE: not the final frontier. Lancet. 2006;368:1215–6.
- Eckstein HH, Reiff T, Ringleb P, et al. SPACE-2: a missed opportunity to compare carotid endarterectomy, carotid stenting, and best medical treatment in patients with asymptomatic carotid stenoses. Eur J Vasc Endovasc Surg. 2016;51:761–5.
- Cleveland TJ, Gaines PA, Venables GS. Carotid artery stenosis: patients should have access to all treatments. BMJ. 2010;340:c1467.
- Hornung M, Bertog SC, Franke J, et al. Evaluation of proximal protection devices during carotid artery stenting as the first choice for embolic protection. EuroIntervention. 2015;10:1362–7.
Source: PubMed